About Bio Green Med Solution, Inc.
https://www.bgmsglobal.comBio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems. It also researches and develops pharmaceuticals. The company was formerly known as Cyclacel Pharmaceuticals, Inc. and changed its name to Bio Green Med Solution, Inc. in September 2022.
CEO
Sing Ee Wong
Compensation Summary
(Year )
Ratings Snapshot
Rating : C-
Price Target
About Bio Green Med Solution, Inc.
https://www.bgmsglobal.comBio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems. It also researches and develops pharmaceuticals. The company was formerly known as Cyclacel Pharmaceuticals, Inc. and changed its name to Bio Green Med Solution, Inc. in September 2022.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q2-2025 | $0 | $1.32M ▼ | $-1.32M ▼ | 0% | $0 | $-1.32M ▲ |
| Q1-2025 | $0 | $5.04M ▲ | $-81K ▲ | 0% | $0 | $-5.04M ▼ |
| Q4-2024 | $0 ▼ | $1.83M ▼ | $-3.05M ▼ | 0% ▲ | $0 | $-1.89M ▲ |
| Q3-2024 | $10K ▲ | $2.19M ▼ | $-1.96M ▲ | -19.57K% ▲ | $0 | $-2.18M ▲ |
| Q2-2024 | $4K | $3.65M | $-3.26M | -81.42K% | $0 | $-3.64M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q2-2025 | $4.28M ▲ | $4.4M ▲ | $770K ▲ | $3.63M ▲ |
| Q1-2025 | $3.45M ▲ | $3.73M ▼ | $672K ▼ | $3.06M ▲ |
| Q4-2024 | $3.14M ▲ | $4.09M ▼ | $6.27M ▼ | $-2.17M ▼ |
| Q3-2024 | $2.98M ▼ | $5.38M ▼ | $6.35M ▼ | $-970K ▼ |
| Q2-2024 | $6M | $8.19M | $7.19M | $999K |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q2-2025 | $-1.32M ▼ | $-1.06M ▲ | $0 | $1.88M ▼ | $825K ▲ | $-1.06M ▲ |
| Q1-2025 | $-81K ▲ | $-3.25M ▼ | $0 | $3.65M ▲ | $313K ▲ | $-3.25M ▼ |
| Q4-2024 | $-3.05M ▼ | $-1.36M ▲ | $0 | $1.61M ▲ | $155K ▲ | $-1.36M ▲ |
| Q3-2024 | $-1.96M ▲ | $-3.07M ▲ | $0 | $-1K ▼ | $-3.02M ▼ | $-3.07M ▲ |
| Q2-2024 | $-3.26M | $-3.08M | $0 | $6.29M | $3.2M | $-3.08M |
CEO
Sing Ee Wong
Compensation Summary
(Year )
Ratings Snapshot
Rating : C-